Original Article

Clinical impact of Intravenosus metilprednizolone in attacs of multiple sclerosis

  • H. Kübra Aşık Çelik
  • Orhan Yağız
  • Arif Çakır
  • Hüsniye Aslan
  • Şirin Saçak
  • Aysel Tekeşin
  • Aytuğ Hayırlı
  • Reyhan Sürmeli
  • Mulla Bozkurt

IMJ 2006;7(1):13-15

Multiple Sclerosis is an otoimmune disease that is characterized by relaps remission periods and results ın fokal neurologic defisits. The aim of this study is to show clinic remission after 7 day 1OOOmg/day I. V. metilprednizolone pulse steroid treatment. 60 patıents between 2004- 2005 are included in this study to assess the elinical spectrum after pulse steroid treatment . After pulse steroid treatment increase in EDSS value is observed.

Keywords: Multiple sclerosis, EDSS